Mangoceuticals, Inc. financial data

Symbol
MGRX on Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
Location
15110 Dallas Pkwy, Suite 600, Dallas, TX
State of incorporation
TX
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 36.9 % -96.7%
Quick Ratio 1.44 %
Debt-to-equity 16.1 % +15.9%
Return On Equity -138 % +58.6%
Return On Assets -119 % +59.3%
Operating Margin -1.17K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.49M shares -85.4%
Common Stock, Shares, Outstanding 2.13M shares -87.3%
Entity Public Float 13.4M USD
Common Stock, Value, Issued 213 USD -87.3%
Weighted Average Number of Shares Outstanding, Basic 2.01M shares +89.7%
Weighted Average Number of Shares Outstanding, Diluted 2.01M shares +89.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 755K USD -45.6%
Cost of Revenue 125K USD -58.8%
General and Administrative Expense 4.22M USD +173%
Operating Income (Loss) -8.86M USD -21.3%
Nonoperating Income (Expense) -242K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9.33M USD -27.8%
Net Income (Loss) Attributable to Parent -9.33M USD -27.4%
Earnings Per Share, Basic 0.32 USD/shares +41.8%
Earnings Per Share, Diluted 0.32 USD/shares +41.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 73.9K USD -94%
Inventory, Net 13.2K USD -38.8%
Assets, Current 104K USD -92.2%
Property, Plant and Equipment, Net 3.06K USD -97%
Operating Lease, Right-of-Use Asset 74.9K USD -43.9%
Intangible Assets, Net (Excluding Goodwill) 14.6M USD
Assets 14.8M USD +827%
Liabilities, Current 1.39M USD +774%
Operating Lease, Liability, Noncurrent 12.2K USD -85.1%
Liabilities 1.4M USD +483%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.66K USD
Retained Earnings (Accumulated Deficit) -18M USD -108%
Stockholders' Equity Attributable to Parent 13.4M USD +888%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 13.4M USD +888%
Liabilities and Equity 14.8M USD +827%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -991K USD +45.2%
Net Cash Provided by (Used in) Financing Activities 268K USD -94.7%
Net Cash Provided by (Used in) Investing Activities -3.52K USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 2.13M shares -87.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.11M USD +9834%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 73.9K USD -94%
Deferred Tax Assets, Valuation Allowance 11.2M USD +457%
Deferred Tax Assets, Gross 11.2M USD +457%
Operating Lease, Liability 81.5K USD -43.2%
Depreciation 6.22K USD +2.34%
Payments to Acquire Property, Plant, and Equipment 3.52K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -2M USD -11.1%
Lessee, Operating Lease, Liability, to be Paid 85.7K USD -45.4%
Operating Lease, Liability, Current 69.3K USD +12%
Lessee, Operating Lease, Liability, to be Paid, Year Two 67.6K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 67.6K USD -5.76%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.15K USD -69%
Deferred Tax Assets, Operating Loss Carryforwards 9.21M USD
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 31.6M USD +216%
Share-based Payment Arrangement, Expense 79.7K USD
Interest Expense 1.76K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%